Works matching AU Desai, Ami V.

Results: 15
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Healthcare utilization disparities among children with high‐risk neuroblastoma treated on Children's Oncology Group clinical trials.

    Published in:
    Pediatric Blood & Cancer, 2024, v. 71, n. 10, p. 1, doi. 10.1002/pbc.31192
    By:
    • Shoag, Jamie;
    • Li, Yimei;
    • Getz, Kelly D.;
    • Huang, Yuan‐Shung;
    • Hall, Matt;
    • Naranjo, Arlene;
    • Richardson, Troy;
    • Desai, Ami V.;
    • Umaretiya, Puja J.;
    • Aziz‐Bose, Rahela;
    • Kelly, Colleen A.;
    • Zheng, Daniel J.;
    • Newman, Haley;
    • Zahler, Stacey;
    • Aplenc, Richard;
    • Bagatell, Rochelle;
    • Bona, Kira
    Publication type:
    Article
    11

    Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531.

    Published in:
    Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31089
    By:
    • Barr, Erin K.;
    • Naranjo, Arlene;
    • Twist, Clare J.;
    • Tenney, Sheena C.;
    • Schmidt, Mary Lou;
    • London, Wendy B.;
    • Gastier‐Foster, Julie;
    • Adkins, E. Stanton;
    • Mattei, Peter;
    • Handler, Michael H.;
    • Matthay, Katherine K.;
    • Park, Julie R.;
    • Maris, John M.;
    • Desai, Ami V.;
    • Cohn, Susan L.
    Publication type:
    Article
    12
    13
    14

    Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 15, p. 2967, doi. 10.1002/cncr.34263
    By:
    • Desai, Ami V.;
    • Applebaum, Mark A.;
    • Karrison, Theodore G.;
    • Oppong, Akosua;
    • Yuan, Cindy;
    • Berg, Katherine R.;
    • MacQuarrie, Kyle;
    • Sokol, Elizabeth;
    • Hall, Anurekha G.;
    • Pinto, Navin;
    • Wolfe, Ian;
    • Mody, Rajen;
    • Shusterman, Suzanne;
    • Smith, Valeria;
    • Foster, Jennifer H.;
    • Nassin, Michele;
    • LaBelle, James L.;
    • Bagatell, Rochelle;
    • Cohn, Susan L.
    Publication type:
    Article
    15

    Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).

    Published in:
    Neuro-Oncology, 2022, v. 24, p. 1776, doi. 10.1093/neuonc/noac087
    By:
    • Desai, Ami V;
    • Robinson, Giles W;
    • Gauvain, Karen;
    • Basu, Ellen M;
    • Macy, Margaret E;
    • Maese, Luke;
    • Whipple, Nicholas S;
    • Sabnis, Amit J;
    • Foster, Jennifer H;
    • Shusterman, Suzanne;
    • Yoon, Janet;
    • Weiss, Brian D;
    • Abdelbaki, Mohamed S;
    • Armstrong, Amy E;
    • Cash, Thomas;
    • Pratilas, Christine A;
    • Corradini, Nadège;
    • Marshall, Lynley V;
    • Farid-Kapadia, Mufiza;
    • Chohan, Saibah
    Publication type:
    Article